Trelegy Ellipta
Trelegy Ellipta is an inhaled medication used for chronic obstructive pulmonary disease (COPD) and certain cases of asthma. It combines three medicines that work together to relax and open the airways, reduce inflammation, and improve lung function. Usually taken once daily, Trelegy helps control symptoms like shortness of breath and wheezing.
- Contains three active ingredients: fluticasone furoate (a corticosteroid), umeclidinium (an anticholinergic), and vilanterol (a long-acting beta-agonist)
- Trelegy is not a rescue inhaler and should not be used for sudden breathing problems
- Patients should inhale the dose deeply and hold their breath briefly for proper medication delivery
- Rinsing the mouth after use helps reduce the risk of oral thrush
-
Trelegy Ellipta Medication Description
Trelegy Ellipta is a triple-action inhaler designed for patients with chronic respiratory conditions such as COPD and certain cases of asthma that require more than one medication for control. By combining fluticasone furoate, umeclidinium, and vilanterol, Trelegy addresses multiple aspects of airway disease: inflammation, bronchoconstriction, and airflow limitation. Fluticasone reduces swelling and irritation in the airways, umeclidinium relaxes airway muscles by blocking muscarinic receptors, and vilanterol helps keep airways open by stimulating beta-2 receptors. This combination provides a powerful and convenient once-daily option for long-term management. Trelegy is not intended for immediate relief of acute symptoms, so patients should keep a rescue inhaler available for sudden breathing difficulties. Proper inhaler technique and adherence to daily dosing are essential for effectiveness. Because the medication includes a corticosteroid, rinsing the mouth after use helps prevent oral thrush. Regular monitoring by a healthcare provider ensures optimal control and minimizes risks. When used correctly, Trelegy can improve breathing and reduce flare-ups for patients with chronic lung disease. -
Trelegy Ellipta Side Effects
Common side effects of Trelegy Ellipta include headache, sore throat, cough, and mild hoarseness. Some patients may experience oral thrush, which can be reduced by rinsing the mouth after use. Serious but less common risks include pneumonia, severe allergic reactions, and worsening of breathing problems. Warning signs such as chest pain, irregular heartbeat, or sudden shortness of breath require immediate medical attention. Regular checkups and proper inhaler technique help minimize these risks. -
Consumer Information Use and Disclaimer
This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.
How TelyRx Works
1. You Choose
Request Your Prescription.
2. Doctors Review
Doctors Prescribe. Pharmacists Dispense.
3. We Deliver
Your Medication Arrives Quickly and Discreetly
Verified Customer Reviews
| Sex | Both |
|---|---|
| Pick and Pack | Yes |
| Order Flagging System | No |
| Set Cart Qty Limit | 4 |
| Robots Meta | INDEX, FOLLOW |

